Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

SMU and UNT Student leaders of College Health Alliance of Texas call on students to cheer safely this weekend as teams meet on the field


News Image

“Although we may be on different teams on the field, we are all on the same team to mitigate COVID-19. The only way we defeat this virus is together,” said Michael Luecke.

Texas college football is returning for the 2020-2021 season amid the coronavirus pandemic with some schools allowing fans in the stadium with limited capacity and tight restrictions while other schools opted out of having fans this year.

College Health Alliance of Texas (CHAT) representatives Austin Hickle, Student Body Vice President at Southern Methodist University and Michael Luecke, Student Body President at University of North Texas are encouraging students to celebrate responsibly as the two teams face-off this weekend at the Apogee Stadium.

“Although we may be on different teams on the field, we are all on the same team to mitigate COVID-19. The only way we defeat this virus is together,” said Michael Luecke.

Founded in response to the coronavirus in an effort to stop the spread of COVID-19, CHAT seeks to promote the importance of public health guidelines and to actively engage students to do their part in preventing further spread of the virus.

“In order for us to protect our future, we must all do our part. Students are allowed to have fun, we just need to do so in a safe and cautious manner,” says Austin Hickle.

The statewide coalition encourages all students to support their respective teams by following best COVID-19 practices from the CDC (The Centers for Disease Control and Prevention) such as wearing masks, maintaining six-feet social distance protocols and through frequent handwashing or use of sanitizers. More recommendations can be found in CHAT’s student guide.

If you would like to set up an interview with CHAT representatives, please contact Crosswind Media and Public Relations at media@crosswindpr.com. For more information about the organization, visit https://collegehealthallianceoftexas.com/

Social Media:

Twitter: @CollegeHealthTX

Instagram: @CollegeHealthTX

Facebook: https://www.facebook.com/CollegeHealthTX

About the College Health Alliance of Texas

The College Health Alliance of Texas is a group of Texas student leaders united to build consensus, stop the spread of COVID-19 and to keep college campuses open by effectively communicating how following simple public health guidelines is in everyone’s best interests.

Share article on social media or email:



ACE Medical Company Receives 510(k) Approval from the FDA


News Image

“Receiving the 510(k) gives us the ability to directly market and sell these products for use in neurosurgery and the spine, representing the largest market share of users for these devices. Our FDA clearance will open up significant domestic and global sales opportunities.”

ACE Medical Co. has been granted 510(k) clearance from the FDA in order to sell and market their surgical equipment for the use in the spine.

According to the FDA, “a 510(k) is a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device.”

This clearance comes as encouraging news to ACE Medical as this means their tried-and-true medical equipment brands has been deemed safe and effective. As a supplier of Kerrison’s tools for removing bone anatomy, ACE Medical can continue to help doctors relieve their patient’s pain and numbness of discogenic origin.

Alex Ebner, President and Founder at ACE Medical Co. has an extensive background and demonstrated history of working in the medical device industry. Ebner is a strong business development professional skilled in the spine and disposables.

“Receiving the 510(k) gives us the ability to directly market and sell these products for use in neurosurgery and the spine, representing the largest market share of users for these devices,” said Ebner. “Our FDA clearance will open up significant domestic and global sales opportunities.”

ACE Medical Co’s dedicated sales and support teams are trained in the most advanced techniques and latest generations of equipment. Known for their trusted expertise, leadership and dedication to bringing the highest quality service and supplies to our surgeons. ACE Medical supplies to physicians that are leaders in their areas of medicine and work collaboratively with them to provide extraordinary care and improved outcomes for patients.

About ACE Medical Co.

ACE Medical Co. is a medical equipment supplier in Cincinnati, Ohio. Their solution-based systems are designed to improve surgical outcomes for both patients and providers. Known for their trusted expertise, leadership and dedication to bringing the highest quality service and supplies to surgeons; they represent premier manufacturers of surgical instrumentation and equipment, for use by Cardiac, ENT, Facial/Plastic, Neuro, Spine and Thoracic specialists. Find more information at: http://www.acemedicalco.com.

Share article on social media or email:

It’s Time to Engage in the Power of Holistic Health by Attending the MaxLiving Fearless Immunity Masterclass


This is a Masterclass like never seen before. Spanning six weeks and five unique topics, the Fearless Immunity Masterclass has been tailor-made to promote health in times of fear.

In the first week, MaxLiving will introduce the concept of “Fearless Immunity” and the essential role the immune systems plays on strengthening the body from the inside out. From the first week, the masterclass will cover the researched information on Cancer Awareness, the Nervous System, Nutrition and Detox, and Fitness Plans.

The six-week masterclass is everything needed to master a principled approach to optimal health, all through the lens of the 5 Essentials® and chiropractic care. These interactive presentations will guide each course with a focus on the cutting edge of natural health. Use this opportunity to refocus on the reality of health and the MaxLiving message of empowerment and wellness. Be sure to take advantage of this unique course and engage in the truths of health and healing!

Find a MaxLiving clinic to learn more about the six-week masterclass and how to attend: https://maxliving.com/locations/

If you are interested in joining the MaxLiving network or in MaxLiving wholesale product opportunities, contact Emily Pugh-Oliver, MaxLiving Doctor Sales Associate, at emily.oliver@maxliving.com.

For press information and media resources, please contact Ray Leake, MaxLiving, at (321) 939-3060, or ray.leake@maxliving.com

MaxLiving is a natural healthcare organization founded on five core principles of wellness. The 5 Essentials™ is a natural and effective way to maximize your health by integrating core chiropractic, mindset, nutrition, exercise and oxygen, and minimizing toxin exposure. Our vision of chiropractic and holistic healthcare is recognized through a group of chiropractor partners and practices. MaxLiving exists to transform lives by providing educational seminars, coaching programs, franchise opportunities, and nutritional products and services. We want to educate about the power of chiropractic care and empower people to live a healthy, balanced lifestyle.

Share article on social media or email:

Contract Manufacturing for Quality in the Time of COVID-19, Upcoming Webinar Hosted by Xtalks


Xtalks Logo

Xtalks Life Science Webinars

With the outbreak of COVID-19, and with an anticipation that this virus will be with us for the foreseeable future, organizations that can maintain quality in their manufacturing operations, and adapt to a changing environment, are best positioned to be successful in this new era.

The dawn of 2020 brought significant changes to everyday life, as well as the way organizations approach manufacturing and quality. With the outbreak of COVID-19, and with an anticipation that this virus will be with us for the foreseeable future, organizations that can maintain quality in their manufacturing operations, and adapt to a changing environment, are best positioned to be successful in this new era. While much is changing, the Manufacturing Triangle – Cost, Quality, and Schedule – is not. Supply chains still need to be met and on time; quality documentation must be generated for satisfactory regulatory compliance; agility in manufacturing volume, often relying on contract manufacturers to allow for rapid increases in volume to meet demand, must be attainable.

To achieve these goals for their customers, contract manufacturers are developing new methods of doing day-to-day work and guiding customers through the contract manufacturing cycle. Developing means of doing remote and virtual customer and supplier interactions and audits in both the quality and manufacturing spaces allow customers to understand how the successful contract manufacturer will be able to adhere to quality standards while adapting to rapidly changing market demands, and will both keep workers safe and ensure the end product meets the same quality standards found in a pre-COVID-19 environment. Balancing the many demands and needs in the COVID-19 era allows customers to bring product to market, without sacrificing quality rapidly.

Join Dave Thoreson, VP Global Operations, Phillips-Medisize, and Cheryl Norder, VP of Quality, Phillips-Medisize, in a live webinar on Tuesday, September 29, 2020, at 11 am EDT (4 pm BST/UK).

For more information or to register for this event, visit Contract Manufacturing for Quality in the Time of COVID-19.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Cardiac Safety in Oncology Drug Development – The Role of ECG and Cardiac Imaging Endpoints From a Cardio-Oncology Perspective, Upcoming Webinar Hosted by Xtalks


Xtalks Logo

Xtalks Life Science Webinars

Cardio-oncology is most frequently associated with a clinical focus on cardiovascular issues associated with the treatment and management of cancer patients, as many oncology therapeutic agents are also cardiotoxic. The collaboration and integrated treatment approach between the fields of cardiology and oncology has led to a proactive treatment approach which, along with improved cancer treatments, has also improved survival rates and quality life for cancer patients. This clinical collaboration is paralleled in the approach to the development of new oncologic therapeutic agents.

Cardiac safety endpoints are important considerations in the development plan for an oncology treatment. With a focus on establishing a benefit-risk profile of new compound and/or the use of an existing treatment for a different indication, there is a need to develop a strategy to define the developing treatment’s cardiac safety profile. Cardiac safety endpoints/modalities in oncology drug development include electrocardiography (ECG), hemodynamics, cardiac imaging (i.e. echo, muga) and laboratory cardiac biomarkers. This webinar will focus on the integration and approaches to implementing ECG and cardiac imaging endpoints into an oncology study and development plan.

Join Jeff Heilbraun, VP, Medical and Scientific Affairs Cardiac Safety Service, Bioclinica and M. Barbara Srichai-Parsia, Associate Professor of Medicine & Radiology , Georgetown University School of Medicine, in a live webinar on Wednesday, September 30, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Cardiac Safety in Oncology Drug Development – The Role of ECG and Cardiac Imaging Endpoints From a Cardio-Oncology Perspective.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com.

For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.

Share article on social media or email:

Dizziland, Inc. Offers Licensing of Advanced Vestibular Treatment™, Promising Improved Care for Patients with Dizziness, Vertigo and Imbalance


Vestibular, vision, brain, BalanceAwarenessWeek, LifeRebalanced, brainfog, dizziness, vertigo, imbalance

Vestibular dysfunction in the inner ear is a leading cause of dizziness, vertigo and imbalance

“Vestibular dysfunction is a leading cause of dizziness, vertigo and imbalance. And, specially trained vestibular audiologists are the most well equipped to diagnose and treat this dysfunction.

Since the dawn of modern medicine, doctors have undergone specialized training to diagnose and treat issues associated with specific systems and parts of the body. Cardiologists specialize in the heart. Pulmonologists specialize in the respiratory system. Podiatrists specialize in the feet and ankles. Specialists, and their respective fields of medicine, provide refined medical skills to better diagnose and treat medical issues associated with specific areas of the human body.

Likewise, audiologists specialize in diagnosing and treating disorders associated with the ear. Many people think hearing is the main function of the ear and solely associate audiologists with diagnosis and treatment of hearing loss. In fact, the ears are organs that provide two main functions — hearing and balance. Therefore, today’s field of audiology also considers the millions of people in the United States and abroad who suffer from dizziness, vertigo and imbalance, as well as hearing loss and tinnitus.

“Contrary to what many people think, the primary function of the inner ear is equilibrium not hearing. Within the inner ear there are two distinct parts: The cochlea, for hearing, and the vestibular system for balance,” says Dr. Howard T. Mango, medical director and CEO of Newport-Mesa Audiology Balance & Ear Institute. “Vestibular dysfunction is a leading cause of dizziness, vertigo and imbalance. And, specially trained vestibular audiologists are the most well equipped to diagnose and treat this dysfunction.”

Notably, 35 percent of adults aged 40 years or older in the United States—approximately 69 million Americans—have experienced some form of vestibular dysfunction. Eighty percent of people aged 65 years and older have experienced dizziness. Falling is one of the leading health concerns for people over the age of 60, and older people with chronic dizziness or imbalance are two to three times more likely to fall in comparison with older people who do not experience these problems. Falls are the leading cause of fatal injury and the most common cause of nonfatal trauma-related hospital admissions among older adults.

Over a period of 30 years, the field of audiology has made huge strides in not only understanding the underlying causes of these widespread conditions, but through the development of advanced medical technology used to diagnose, treat and rehabilitate the patients who suffer from them.

Less than 15 years ago, videonystagmography (VNG), which tests only one portion of the inner ear, was the industry standard for diagnosing vestibular dysfunction. However, studies reveal 68 percent of patients with vestibular dysfunction were missed when only a VNG was performed. Now, sophisticated audiologists perform highly sensitive and very specific comprehensive diagnostic testing of all 10 vestibular end organs in the left and right inner ears.

Diagnostic advancements have outpaced advances in vestibular treatment. Though audiologists now diagnose vestibular dysfunction with great precision, many patients are still referred for treatment of dizziness, vertigo and imbalance to physical therapists who do not specialize in the vestibular system. In fact, traditional vestibular rehabilitation therapy directed by physical therapists delivers clinical efficacy of 50-70 percent, leaving 30-50 percent of patients without significant measurable improvement.

Now, there is a new, more effective, specialist-driven approach to the treatment of vestibular dysfunction. Audiologist-directed Advanced Vestibular Treatment™, which delivers nearly 90 percent clinical efficacy, providing many more patients who suffer from dizziness, vertigo and imbalance with significant measurable improvement.

In an age of specialization, audiologists can now diagnose and treat patients with vestibular dysfunction in one location. Through a nationwide licensing program, Dizziland, Inc. is licensing Advanced Vestibular Treatment (and the intellectual property it comprises), which was developed by Newport-Mesa Audiology Balance & Ear Institute, one of the most successful balance centers in the country.

In a critical time where many baby boomers are aging and the U.S. population is further struggling with debilitating vestibular dysfunction, Advanced Vestibular Treatment is poised to more effectively (and conveniently) help patients who suffer from dizziness, vertigo and imbalance. It also stands to benefit audiology practices that are struggling in the COVID-19 environment and ease the burden on the country’s health care system.

If you are an audiologist and would like to learn more about how Advanced Vestibular Treatment is bringing the diagnosis and treatment of vestibular dysfunction into the 21st Century, please visit http://www.dizziland.com/AVT.

About Newport-Mesa Audiology Balance & Ear Institute

Newport-Mesa Audiology Balance & Ear Institute is one of the country’s leading practices for the research, diagnosis and treatment of patients with vestibular dysfunction. Serving national and international patients, the Institute’s team of doctors of audiology utilize advanced, state-of-the-art technology in Newport Beach, California. The Institute provides both comprehensive diagnostic testing and proprietary Advanced Vestibular Treatment™ with a nearly 90 percent success rate. A full spectrum of audiological solutions is also offered to enhance hearing health, including adult and pediatric hearing loss evaluation, advanced hearing devices and tinnitus treatment. Since 1977, the Institute has served more than 50,000 patients. 500 Old Newport Blvd., Suite 101, Newport Beach, CA 92663 | 949.642.7935 | http://www.dizziland.com.

About Dizziland, Inc.

Dizziland, Inc. licenses the intellectual property of Newport-Mesa Audiology Balance & Ear Institute. Intellectual property includes, patents, clinical diagnostic and treatment protocols, copyrights and trademarks, as well as specialized business know-how. Through licensing this proven intellectual property to select practitioners throughout the country, Dizziland, Inc. is striving to make highly effective audiologist-directed Advanced Vestibular Treatment™ available to all patients who suffer from dizziness, vertigo and imbalance – bringing the diagnosis and treatment of vestibular dysfunction into the 21st century. 500 Old Newport Blvd., Suite 200, Newport Beach, CA 92663 | 949.432.5219 | http://www.dizziland.com/AVT

Share article on social media or email:

Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as Chairman of the Board of Directors


News Image

“Alex’s deep understanding of our industry and keen strategic insights will bring an important perspective to the Board as we transition to a clinical stage company with multiple products in development.” – Jeffrey Strovel, PhD, Chief Executive Officer of Veralox

Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Alex Martin as Chairman of the Board of Directors.

Mr. Martin brings to the Chairman’s role over 25 years of experience in senior executive roles in the life sciences industry, with a focus on business development, operations, and financing. He is currently the Chief Executive Officer of Palladio Biosciences, a clinical stage biopharmaceutical company developing medicines for orphan diseases of the kidney. Mr. Martin was previously Chief Executive Officer of Realm Therapeutics, which was acquired by ESSA Pharma in July 2019, and has held executive roles at biopharmaceutical companies including Intercept Pharmaceuticals (ICPT) as Chief Operating Officer and BioXell as Chief Financial Officer. He began his career at SmithKline Beecham and later became Vice President, Global Business Development & Licensing at Novartis.

“I am thrilled to welcome Alex as Chairman of our Board of Directors,” said Jeffrey Strovel, PhD, Chief Executive Officer of Veralox. “He is an accomplished industry leader who brings a strong track record in operational, business and drug development experience. Alex’s deep understanding of our industry and keen strategic insights will bring an important perspective to the Board as we transition to a clinical stage company with multiple products in development.”

“It’s an honor to be appointed Chairman and I’m excited for the opportunity to leverage my experience to provide additional perspectives and insights at such an important time in Veralox’s evolution,” added Martin. “Heparin-induced thrombocytopenia (HIT) is a life-threatening disease where the only approved treatment still carries the risk of significant bleeding and mortality, and Veralox’s lead candidate, VLX-1005, could be a game changer for people suffering from this condition. I look forward to working with Jeff and the entire Veralox Board to further develop this opportunity.”

Mr. Martin received his B.A. from Cornell University and an M.B.A. from Harvard University.

About Veralox Therapeutics

VERALOX Therapeutics Inc. (https://veralox.com/) is developing first-in-class therapeutics that target the underlying pathologies of diseases with unmet medical needs. The company’s lead candidate, VLX-1005, will be developed initially to treat patients with heparin-induced thrombocytopenia (HIT) and HIT with thrombosis (HITT). Second generation therapeutic products are under development for type 1 diabetes (T1D) as well as other immune-mediated and inflammatory diseases.

Share article on social media or email:

NeoTract Designates Dr. Guillermo Patino as UroLift® Center of Excellence


News Image

“This designation recognizes Dr. Guillermo Patino as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Guillermo Patino, M.D., Las Vegas Urology in Las Vegas, NV, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Patino has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Guillermo Patino as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Surrogacy Agencies’ Importance Highlighted by Groundbreaking Citizenship Ruling, says Global Surrogacy Services


The Los Angeles based surrogacy agency provides assistance for intended parents of all genders, and orientations.

A September 1 article on Sky News reported on the outcome of a lawsuit filed after the daughter of an American same-sex couple who was born abroad via surrogacy was initially not granted U.S. citizenship. The article reported that the U.S. State Department did not consider the girl to be a citizen because she was born “out of wedlock” and her biological parent had lived outside of the U.S. for five years before his daughter’s birth. A judge ruled that, although the girl was born in the U.K. via surrogate, she has been an American citizen since birth as both her parents are American. Los Angeles-based Global Surrogacy Services celebrates this groundbreaking decision, saying that, while this is a positive step toward gestational equality, the struggle is far from over.

Global Surrogacy Services says that intended parents of all backgrounds, fertility statuses, and sexual orientation deserve the same rights granted to traditional families. The Los Angeles surrogacy agency says that, unfortunately, there are many legal hurdles to jump through for intended parents and that becomes even more so for those who are seeking LGBTQ services. It adds that this case serves as a powerful reminder of how important it is to have all legal affairs in order before proceeding with the surrogacy process in order to avoid the issues faced by the couple profiled in the article.

The Southern California firm adds that the process of finding the right surrogate, as well as navigating through the complicated legalities that come with surrogacy, can be difficult without the professional guidance of an agency. Global Surrogacy Services says that the legalities of gestational surrogacy that crosses state lines are already complex and are only made that much more intricate if multiple countries are involved, or if one of the intended parents has a complex immigration history.

Global Surrogacy Services says that an agency can help intended parents smoothly navigate through all the complications and legal challenges that come with the surrogacy process. The agency notes that, when intended parents don’t have to worry about all of the fine print, they can focus more on the joys of parenthood and creating a loving home for their family.

Readers interested in learning more about Los Angeles-based LGBTQ-friendly surrogacy agency Global Surrogacy Services can call (800) 355-2009 or visit its website at https://globalsurrogacyservices.com/.

Share article on social media or email:

Stewart Kohl Shares the VeloSano Story


Stewart Kohl - Velosano Bike to Cure

Stewart Kohl – Velosano Bike to Cure

Whether you are cycling five miles or going the full distance, we are all achieving something greater than the sum of our individual contributions. We are building a community and racing for a cure.

Stewart Kohl has long been passionate about cycling and philanthropy, so it was natural to bring those things together. As Co-CEO of The Riverside Company, an $8.5 billion global private equity firm, Stewart Kohl has been able to build on a vision with VeloSano.

Latin for “swift cure,” VeloSano is a community-driven, year-round fundraising event supporting cancer research at Cleveland Clinic. Since its founding in 2014, it has raised more than $23 million to directly fund lifesaving cancer research. VeloSano has supported over 125 cancer research projects, and generated more than $22 million in additional, third-party grants have been received as a result of the promise shown by VeloSano-funded projects.

“Being on a bike is a magical, almost spiritual, experience,” said Kohl. “It connects you with the world around you and the beauty of nature, helps manage stress and we know that physical activity is a great way to stay healthy. When I began participating in charity rides in 1990s, it was love at first pedal stroke.”

VeloSano was originally inspired by the Pan-Mass Challenge. The Pan-Mass Challenge began in 1980 by Billy Star as a fundraising bike-a-thon to benefit the Dana-Farber Cancer and has grown to become the most-successful athletic fundraiser in the country.

“When I participated in my first Pan-Mass Challenge in 1998, I knew it was more than just a bike ride,” said Kohl. “The camaraderie, the appreciation from cancer patients, the inspirational stories from survivors. I decided that we absolutely had to have an event like this in Cleveland.”

Prior to joining The Riverside Company in 1993, Kohl was a vice president of Citicorp Venture Capital, Ltd., the private equity arm of Citibank and has balanced finance and philanthropy throughout his professional life, with a particular focus on Cleveland.

Kohl serves on the board of Oberlin College, the Museum of Contemporary Art Cleveland, and the Board of Trustees of Cleveland Clinic as well as its Wellness Institute Leadership Board. He was inducted into the Ohio Foundation of Independent Colleges Hall of Excellence in 2009. He previously served as Co-Chair of the Building for Hope Capital Campaign of the Center for Families and Children. Giving back is part of his DNA.

Stewart Kohl joined the Board of Directors for the Cleveland Clinic in 2013. The Clinic had been looking to host a major fundraising event to benefit cancer research, including its acclaimed Taussig Cancer Center. The Clinic’s philanthropy team worked alongside Kohl to build an event in Cleveland similar to the Pan-Mass Challenge.

The Kohl Fund served as the founding donor and VeloSano rapidly attracted donors and participants from all over Northeastern Ohio. Sponsors like Jones Day, Adcom, Zack Bruell Events, Lexus, and even the beloved Cleveland Indians Major League baseball team have lent their support to this annual event.

“Riders choose from route options ranging from 10-200 miles,” said Kohl. “Each rider commits to raise a particular amount of money and 100 percent of the money raised is awarded directly to research by spring of the following year.”

VeloSano boasts an incredibly dedicated staff and many volunteers working to ensure that the event is a success.

“If people don’t have an amazing time, they won’t participate again, so we make sure it is amazing,” said Kohl. “The VeloSano team ensures that every small detail is covered, from the incredible food to finding the most energetic and inspired volunteers. They ensure absolutely everything is thought of and thought through, because we need repeat riders to keep building on our success.”

A big reason people return is because cancer is so personal for almost everyone.

“The weekend experience is powerfully transforming,” said Kohl. “We come together with one shared goal but there are thousands of unique stories – survivors, children and family members of survivors – cancer has touched so many lives in profound ways. Whether you are cycling five miles or going the full distance, we are all achieving something greater than the sum of our individual contributions. We are building a community and racing for a cure.”

At Cleveland Clinic Taussig Cancer Center is one of the world’s top research and treatment facilities, and VeloSano funding fuels research that might otherwise never happen.

This year’s VeloSano was virtual due to the COVID-19 pandemic, which presented both challenges and opportunities, Kohl said.

“The energy of an in-person event is spectacular, but being virtual means people can participate anywhere in the world and in whatever manner they choose – it has opened VeloSano to a whole new set of participants.”

VeloSano’s funds are needed now more than ever. “Cancer doesn’t slow down for a pandemic and neither does VeloSano,” said Stewart Kohl.

Share article on social media or email: